跳至主要内容
临床试验/NCT02117726
NCT02117726Unknown4 期

Impact of Various Sedation Regimens on the Incidence of Post-sedation Delirium in Patients Receiving Mechanical Ventilation

Shandong Provincial Hospital7 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2014年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
320
试验地点
7
主要终点
Incidence rates and duration of delirium

研究概览

简要总结

Sedation drugs that are commonly used in ICU in treatment of ARDS, includes propofol, midazolam and dexmedetomidine . Among these, both dexmedetomidine and propofol have been reported to be used together with midazolam in ICU and the combination of propofol and midazolam is most commonly used, but things follow include a high incidence rate of delirium, But the combination of midazolam and dexmedetomidine may have complementary advantages and could have be a better choice for sedation. In this study, we attempted to observe the effects of two different drug regimens on delirium incidence rates in severe ARDS patients' : midazolam and propofol vs propofol and dexmedetomidine .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects willing to give written informed consent.
  • Mild, moderate or severe ARDS patients demanding invasive mechanical ventilation.
  • Subjects whose expected time of mechanical ventilation is longer than 24 hours.
  • Subjects aged between 18 and 70.

排除标准

  • Subjects with extremely unstable circulation, whose SBP lower than 90mmHg after volume expansion or pressor agent treatment.
  • Subjects with extremely unstable circulation, whose SBP lower than 90mmHg after volume expansion or pressor agent treatment.
  • Subjects with heart rates less than 50 beats per minute.
  • Subjects with second or third degree atrioventricular block.
  • Subjects with serious cerebral injury, severe neurologic disorder (e.g acute stroke, uncontrolled epilepsy and severe dementia) or coma.
  • Subjects with acute or severe liver disease (Child-Pugh class C), see attachment
  • ARDS patients caused by pulmonary fibrosis or COPD.
  • Subjects on all types hemodialysis.
  • Subjects with neuromuscular system disease, alcohol withdrawal syndrome or mental disease before entrance of ICU.
  • Subjects suspected of narcotic analgesics abusing.
  • Subjects needing neuromuscular blocking agents (except intubation).
  • Subjects allergic to investigational products or with other contraindication.
  • Subjects who are breastfeeding or pregnant
  • Subjects participated in other study within 30 days before entrance of ICU

研究组 & 干预措施

Dexmedetomidine,midazolam

Experimental

Slow injection of 2mg midazolam every minute and watching patients' reaction until attaining the target level of sedation;midazolam was maintained at 0.02~0.1mg/kg/h, for 24 hours.Dexmedetomidine will be added at 0.2~1.4μg/kg/h to maintain sedation.If target sedation level (RASS score) cannot be reached in maximum dose of dexmedetomidine, continuous intravenous infusion of midazolam could be used at 0.02~0.1mg/kg/h, until the target level is reached.

干预措施: Dexmedetomidine,midazolam (Drug)

Propofol,midazolam

Active Comparator

Slow injection of 2mg midazolam every minute and watching patients' reaction until attaining the target level of sedation;midazolam was maintained at 0.02~0.1mg/kg/h, for 24 hours.Propofol will be added at 0.3~4mg/kg/h to maintain sedation.If target sedation level (RASS score) cannot be reached in maximum dose of propofol, continuous intravenous infusion of midazolam could be used at 0.02~0.1mg/kg/h, until the target level is reached.

干预措施: Propofol,midazolam (Drug)

结局指标

主要结局

Incidence rates and duration of delirium

时间窗: up to 15 days

Incidence rates and duration of delirium within 14 days after initiation of sedation with dexmedetomidine or propofol

Sedation interruption

时间窗: up to 5 days

Eye opening according to the voice orders, eye tracking, clenching fist and nodding are involved in assessment, patients could do 3 of those or more is deemed as conscious and taken in delirium assessment.

次要结局

  • Hospitalized days in ICU(up to 15 days)
  • Variation degree of HR, RR, BP and SpO2(up to 15 days)
  • Sedation therapy effect(up to 7 days)
  • Death rates(28 days)
  • Incidence rate of patients self-extubation(up to 7 days)
  • Injection speed, total dose and injection of sedatives in different groups.(7 days)
  • Additional dose of fentanyl and midazolam(up to 7 days)
  • Dosage of diuretic, antiemetic, hypoglycemic, beta-receptor antagonist and vasoactive agents.(up to 15 days)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Wangchunting

Director

Shandong Provincial Hospital

研究点 (7)

Loading locations...

相似试验

Impact of Various Sedation Regimens on the Incidence... | 临床试验